Lymphatic Filariasis Elimination Program updates, Nepal

2

Lymphatic Filariasis Elimination Program updates, Nepal

Lymphatic Filariasis Burden in Nepal

    • Endemic districts: 61
    • Average prevalence: 13%
    • Population at risk: 25 million
    • Causative agent: Wuchereria bancrofti
    • Transmission vector : Culex quinquefasciatus
    • Reported chronic conditions : > 30,000; majority are hydrocele

DOWNLOAD MATERIALS FOR MDA PLANNING 2019

Lymphatic Filariasis Elimination Program, Nepal

Goal

  • To eliminate LF as a public health problem by 2020

Target

  • To cover with MDA all LF endemic districts by 2014 and achieve <1% prevalence in all endemic districts by 2020

Strategy

  • Interruption of transmission by MDA – Diethylcarbamazine (DEC) and Albendazole, yearly campaign for six years
  • Morbidity management & Disability Prevention

LF Elimination Strategies & Steps

  • Interruption of transmission by Mass Drug Administration (MDA) using two drugs regimen, Diethylcarbamazine (DEC) and Albendazole, once yearly for six years.
  • Morbidity Management by self care and with support using intensive but simple, effective and local hygiene technique.

Monitoring and Evaluation During and After MDA

  • Coverage is monitored at each MDA round to determine whether the goal of at least 65% coverage of the total population was met.
  • After at least five rounds of effective MDA, the impact is evaluated at sentinel and spot-check sites.
  • If all the eligibility criteria are met, a transmission assessment survey (TAS) is conducted before deciding to stop MDA.
  • TAS is repeated twice during post-MDA surveillance phase.

Progress Towards LF Elimination: As of Dec 2018

  • Mapping done: 2001,2005/2006, 2012
  • Geographical Coverage: MDA started from 1 district in 2003 & Reached 100% in 2013,
  • MDA stopped in 46 districts after TAS 1
  • 2 districts are scheduled for TAS 1 in 2019
  • TAS 2 succeeded in14 districts & TAS 3 succeeded in 5 districts
  • Almost 110 million doses of MDA drugs administered.
  • Post MDA surveillance and morbidity management ongoing.
  • 12 districts completed MMDP mapping using Measure SMS Reporting and expanding rapidly.

Morbidity Management and Disability Prevention (MMDP) Status – 2018

  • Free Hydrocele Surgery done – 7327 cases (Till 2018) and free surgeries ongoing in all endemic districts.
  • Morbidity mapping completed in 12 districts and 9 more in plan for 2019 (9511 Cases)
  • Successful Integration with LF and leprosy self care in 1 (Lalgadh) Hospital & in talk with few others.

Source of Info: EDCD Presentation 



DOWNLOAD MATERIALS FOR MDA PLANNING 2019


Egypt eliminates lymphatic filariasis
Diseases Control Program in Nepal : Lymphatic Filariasis
Descriptive Epidemiology of Scrub Typhus in Nepal, 2017
Bye – Bye 👋👋👋 Trachoma 👁‍🗨👁‍🗨 from Nepal 🇳🇵
Classification of Water-related diseases
Malaria Micro Stratification Report 2018

Print Friendly, PDF & Email
Read also:  10 facts on breastfeeding
Share.

About Author

Sagun's Blog is a Public Health Information sharing platform created by Sagun Paudel. The main purpose of this blog is to share public health updates.

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.